Indian pharma players shifting to specialty business due to pricing pressure in US: Nirmal Bang
Updated : September 17, 2019 09:56 AM IST
Pharma biggies are finally opening up in China to carve a niche in complex generics.
Players that are aggressively looking into the opportunity are Dr Reddy’s Laboratories, Sun Pharmaceuticals and Aurobindo Pharma.
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morning
YOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more